Novalac is a brand leader in infant nutrition and pediatric gastroenterology. With a comprehensive product range, Novalac is present all around the world in more than 60 markets. Its innovative products are developed and marketed by United Pharmaceuticals SAS (headquarters in Paris) and its subsidiary UP International SA (Swiss subsidiary in Geneva), and distributed worldwide through its alliance with some of the world’s top pharmaceutical companies. Thanks to our 20 years of experience, and with a significant and ongoing investment in research and development, our range of products is original, complete and constantly evolving, and the subject of numerous clinical studies that have been published in reputable journals. The Novalac products assist babies at each stage of their development and provide their daily nutritional requirements (together with a diversified diet after the age of 6 months). As the well-being and health of infants is our main concern, our products are developed in strong collaboration with healthcare professionals and respect the highest standards in quality and production.